Posner Christopher — SEC Form 4 filings

SEC reporting owner CIK 1748265. 8 Form 4 filings on record with FilingPulse; latest filed 2025-03-04.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2024-02-05 to 2025-03-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cara Therapeutics, Inc. (CARA)PRESIDENT AND CEO, Director88 legs · 59,098 sh · $36,7801

Form 4 filings — Posner Christopher

FiledFormIssuerReported transactionsSource
2025-03-044Cara Therapeutics, Inc. (CARA)Sale (S): 583 @ $4.75EDGAR
2025-02-064Cara Therapeutics, Inc. (CARA)Sale (S): 372 @ $4.72EDGAR
2024-11-064Cara Therapeutics, Inc. (CARA)Sale (S): 3,668 @ $0.29EDGAR
2024-08-024Cara Therapeutics, Inc. (CARA)Sale (S): 4,149 @ $0.35EDGAR
2024-05-064Cara Therapeutics, Inc. (CARA)Sale (S): 3,936 @ $0.75EDGAR
2024-03-044Cara Therapeutics, Inc. (CARA)Sale (S): 5,834 @ $0.89EDGAR
2024-02-124Cara Therapeutics, Inc. (CARA)Sale (S): 35,575 @ $0.53EDGAR
2024-02-054Cara Therapeutics, Inc. (CARA)Grant/award (A): 62,500 @ $0 · Sale (S): 4,981 @ $0.55EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1748265 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →